Macrophage heterogeneity in liver fibrosis
Open accessThe DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Abstract
Liver fibrosis represents a universal pathological endpoint in chronic hepatic disorders, in which hepatic macrophages play a pivotal role through dynamic phenotypic modulation. These versatile immune cells undergo functional and phenotypic transformations mediated by diverse molecular mediators, with their heterogeneity arising from both cellular origin differences and disease-specific microenvironments. The development of technologies such as single-cell and spatial omics has broken through the traditional M1/M2 classification paradigm of macrophages, revealing the molecular signatures and functional distinctions of hepatic macrophages during liver injury, fibrogenesis, and regression. Hepatic macrophages are central to the pathogenesis of chronic liver injury and considered as potential targets for drug discovery. While numerous macrophage-targeting strategies for liver fibrosis intervention currently remain in preclinical development, advancing our comprehension of macrophage plasticity and subset-specific functions holds significant potential. A deeper understanding of macrophage heterogeneity could provide a new therapeutic strategy against liver fibrosis, ultimately improving clinical outcomes for patients with chronic liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 2×
“Speci fi cally, IFN-g and TLR-activated IRF-STAT1-signaling pathways orient macrophage function toward the pro-in fl ammatory phenotype, whereas IL-4 and IL-13 activate alternatively activated macrophages through STAT6 (70).”
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Self-citationTissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L., Garner, H., Trouillet, C., de Bruijn, M. F., Geissmann, F., et al. (2015) · Nature · doi:10.1038/nature13989 · Cited by 2,339
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274 · cited 1×
“The farnesoid X receptor (FXR) is a bile acid-activated nuclear receptor that is abundantly expressed in the liver and intestine (161).”
Identification of splenic reservoir monocytes and their deployment to inflammatory sites
Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J.-L., Kohler, R. H., Chudnovskiy, A., Waterman, P., et al. (2009) · Science · doi:10.1126/science.1175202 · Cited by 2,221
Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107
The metabolic signature of macrophage responses
Viola, A., Munari, F., Sánchez-Rodríguez, R., Scolaro, T., & Castegna, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01462 · Cited by 2,021 · cited 2×
“These interruptions lead to the accumulation of itaconate and succinate, which are critical metabolites that contribute to the pro-in fl ammatory phenotype of macrophages (44).”
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
Self-citationLiver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424 · cited 1×
“In the healthy liver, monocyte-derived macrophages (MoM f s) predominantly localize to the portal triad region, where they maintain iron homeostasis and regulate cholesterol metabolism (15).”
Self-citationPalsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.005 · Cited by 1,397
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Ivashkiv, L. B. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0029-z · Cited by 1,358
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)33041-7 · Cited by 1,277 · cited 12×
“However, CVC maintained a favorable safety pro fi le and was well tolerated in this cohort with MASH and liver fi brosis (168).”
InfluentialSeitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages
Rath, M., Müller, I., Kropf, P., Closs, E. I., & Munder, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00532 · Cited by 1,262
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Macrophage heterogeneity in liver injury and fibrosis
Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061 · cited 1×
“Macrophages are also extremely plastic, as demonstrated by their ability to alter their phenotype to adapt to the liver microenvironment and perform different functions (5).”
Self-citationIntracellular NOD-like Receptors in Host Defense and Disease
Kanneganti, T.-D., Lamkanfi, M., & Núñez, G. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.002 · Cited by 1,061
A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells
Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano, A., & Geissmann, F. (2006) · Science · doi:10.1126/science.1117729 · Cited by 1,053 · cited 1×
“MoM f s are Cluster of Differentiation 11b (CD11b) + , F4/80 intermediate (int) , Lymphocyte antigen 6 complex locus C (Ly6C) + and CSF1R + , which are derived from bone marrow (BM) C-X3-C motif chemokine receptor 1 CX3CR1 + CD117 + Lin - progenitor cells (16, 17).”
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003 · cited 3×
“Currently, strategies to interfere with chemokine signal transduction include the use of monoclonal antibodies, receptor antagonists, or small-molecule inhibitors to block chemokine-induced intracellular signaling (8).”
InfluentialSelf-citationRamachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
Guilliams, M., Bonnardel, J., Haest, B., Vanderborght, B., Wagner, C., Remmerie, A., Bujko, A., Martens, L., Thoné, T., Browaeys, R., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.018 · Cited by 985 · cited 1×
“Single-cell analysis has revealed that recruited macrophages exist in two subsets with distinct activation states, either CCR2 + , CX3CR1 + , Ly-6C hi monocytes or TREM2 +, CD63 + , CD9 + lipid-associated macrophages (LAMs) (98, 99).”
Notch Signaling in Development, Tissue Homeostasis, and Disease
Siebel, C., & Lendahl, U. (2017) · Physiological Reviews · doi:10.1152/physrev.00005.2017 · Cited by 978 · cited 1×
“Notch signaling, known for its critical role in liver development, is also involved in liver regeneration, carcinogenesis, and metabolism (72).”
Macrophages: Development and Tissue Specialization
Varol, C., Mildner, A., & Jung, S. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112220 · Cited by 962 · cited 1×
“The murine system features two principal circulating monocyte subsets characterized by Ly-6C expression levels: pro-in fl ammatory Ly-6C high (Ly-6C hi ) monocytes and patrolling Ly-6C low (Ly-6C low ) monocytes (19).”
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866 · cited 1×
“Injury-induced in fl ammation prompts the recruitment of macrophages to the liver, where they secrete pro-in fl ammatory cytokines that activate HSCs, thereby initiating liver fi brosis (6).”
Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells
Scott, C. L., Zheng, F., De Baetselier, P., Martens, L., Saeys, Y., De Prijck, S., Lippens, S., Abels, C., Schoonooghe, S., Raes, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms10321 · Cited by 860 · cited 1×
“Furthermore, MoM f s can replace KCs when they are experimentally depleted due to liver injury, and these macrophages can subsequently acquire a phenotype that is almost identical to that of KCs (22, 23).”
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2023.101133 · Cited by 844 · cited 1×
“…in different liver fi brosis induced by multiple disease 6.1 Metabolic dysfunction-associated steatotic liver disease Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease, is characterized by excessive hepatic lipid accumulation (88).”
InfluentialRoles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829
Self-citationHepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
Self-citationA Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Francque, S. M., Bedossa, P., Ratziu, V., Anstee, Q. M., Bugianesi, E., Sanyal, A. J., Loomba, R., Harrison, S. A., Balabanska, R., Mateva, L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2036205 · Cited by 801
Feige, J. N., Gelman, L., Michalik, L., Desvergne, B., & Wahli, W. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.12.002 · Cited by 786
Comparison of gene expression profiles between human and mouse monocyte subsets
Ingersoll, M. A., Spanbroek, R., Lottaz, C., Gautier, E. L., Frankenberger, M., Hoffmann, R., Lang, R., Haniffa, M., Collin, M., Tacke, F., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235028 · Cited by 729 · cited 3×
“Ly-6C hi monocytes are characterized by their expression of in fl ammatory chemokine receptors, pattern recognition receptors, and cytokines, whereas Ly-6C low monocytes demonstrate a patrolling function within the liver and exhibit a higher expression of scavenging receptors (20).”
InfluentialSelf-citationKang, K., Reilly, S. M., Karabacak, V., Gangl, M. R., Fitzgerald, K., Hatano, B., & Lee, C.-H. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.002 · Cited by 699
Wen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695
Self-citationCurrent and future pharmacological therapies for NAFLD/NASH
Sumida, Y., & Yoneda, M. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1415-1 · Cited by 667 · cited 1×
“Emricasan, a pan-caspases inhibitor, reduces in fl ammation and apoptosis by inhibiting KCs activation caused by NLRP3 in fl ammasome cascades (156, 157).”
Remmerie, A., Martens, L., Thoné, T., Castoldi, A., Seurinck, R., Pavie, B., Roels, J., Vanneste, B., De Prijck, S., Vanhockerhout, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.004 · Cited by 592
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 581 · cited 1×
“Macrophage polarization is controlled by a variety of molecular mechanisms, mainly including metabolic reprogramming, autophagy, iron metabolism, Signal Transducer and Activator of Transcription (STAT) and Notch signaling pathways (35, 42) (Figure 2).”
Wang, J., & Kubes, P. (2016) · Cell · doi:10.1016/j.cell.2016.03.009 · Cited by 537
Lu, Y., Yang, A., Quan, C., Pan, Y., Zhang, H., Li, Y., Gao, C., Lu, H., Wang, X., Cao, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32283-3 · Cited by 517 · cited 1×
“The present investigation identi fi es MMP9 + macrophages as the pivotal drivers of end-stage hepatocellular carcinoma in patients with chronic HCV infection (143).”
Metabolism, metabolites, and macrophages in cancer
Li, M., Yang, Y., Xiong, L., Jiang, P., Wang, J., & Li, C. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01478-6 · Cited by 507 · cited 2×
“These macrophages are characterized by augmented fatty acid oxidation (FAO), reduced expression of ferritin, lower levels of glutathione, decreased production of COX2, heightened COX1 expression, weak iNOS activity, and enhanced Arg1 activity (47).”
Self-citationHarrison, S. A., Wong, V. W.-S., Okanoue, T., Bzowej, N., Vuppalanchi, R., Younes, Z., Kohli, A., Sarin, S., Caldwell, S. H., Alkhouri, N., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.027 · Cited by 497
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Kitade, H., Chen, G., Ni, Y., & Ota, T. (2017) · Nutrients · doi:10.3390/nu9040387 · Cited by 492 · cited 1×
“It inhibits the activation of JNK/P38 and NF-k B signaling pathways by suppressing T-cell activity, macrophage recruitment, and KCs activation (175).”
Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
Cheng, K., Cai, N., Zhu, J., Yang, X., Liang, H., & Zhang, W. (2022) · Cancer Communications · doi:10.1002/cac2.12345 · Cited by 460 · cited 1×
“Moreover, these polarized states demonstrate bidirectional interconversion when exposed to speci fi c microenvironmental stimuli (33).”
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Self-citationMacrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Sica, A., Invernizzi, P., & Mantovani, A. (2014) · Hepatology · doi:10.1002/hep.26754 · Cited by 422 · cited 1×
“Additionally, IL-10 and IL-3 activate STAT3 and STAT5, respectively, to promote alternatively activated macrophage polarization (71).”
Sakai, M., Troutman, T. D., Seidman, J. S., Ouyang, Z., Spann, N. J., Abe, Y., Ego, K. M., Bruni, C. M., Deng, Z., Schlachetzki, J. C. M., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.09.002 · Cited by 418
Liver macrophages in health and disease
Guilliams, M., & Scott, C. L. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.002 · Cited by 395 · cited 1×
“KCs-speci fi c markers in mice include C-type lectin domain family 4 member F (CLEC4F), V-set and immunoglobulin domain containing 4 (VSIG4), C-type lectin domain family 2 (CLEC2), and Folate receptor 2 (FOLR2), whereas in humans no consensus has been reached (12).”
Macrophage polarization and plasticity in health and disease
Biswas, S. K., Chittezhath, M., Shalova, I. N., & Lim, J.-Y. (2012) · Immunologic Research · doi:10.1007/s12026-012-8291-9 · Cited by 394
Daemen, S., Gainullina, A., Kalugotla, G., He, L., Chan, M. M., Beals, J. W., Liss, K. H., Klein, S., Feldstein, A. E., Finck, B. N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108626 · Cited by 378
The Transcription Factor Gata6 Links Tissue Macrophage Phenotype and Proliferative Renewal
Rosas, M., Davies, L. C., Giles, P. J., Liao, C.-T., Kharfan, B., Stone, T. C., O’Donnell, V. B., Fraser, D. J., Jones, S. A., & Taylor, P. R. (2014) · Science · doi:10.1126/science.1251414 · Cited by 377 · cited 1×
“PMs selectively express the transcription factor GATA6, which is not expressed by either liver-resident KCs or circulating monocytes (24).”
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371 · cited 2×
“In 2000, Mills et al. categorized macrophages into two distinct subtypes, M1 and M2, based on differences in their metabolism, secretion, and function (31).”
Chalasani, N., Abdelmalek, M. F., Garcia-Tsao, G., Vuppalanchi, R., Alkhouri, N., Rinella, M., Noureddin, M., Pyko, M., Shiffman, M., Sanyal, A., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.296 · Cited by 358
Yu, X., Lan, P., Hou, X., Han, Q., Lu, N., Li, T., Jiao, C., Zhang, J., Zhang, C., & Tian, Z. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.018 · Cited by 356 · cited 1×
“During immune activation in human and rodent infections, hepatitis B virus suppresses NF-k B pathway and ROS production in LPS-induced KCs, thereby inhibiting NOD-like receptor thermal protein domain associated protein 3 (NLRP3) in fl ammasome activation and IL-1 b production (132).”
Thomas, J. A., Pope, C., Wojtacha, D., Robson, A. J., Gordon-Walker, T. T., Hartland, S., Ramachandran, P., Van Deemter, M., Hume, D. A., Iredale, J. P., et al. (2011) · Hepatology · doi:10.1002/hep.24315 · Cited by 346
Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl‐p53 pathway
Zhou, Y., Que, K., Zhang, Z., Yi, Z. J., Zhao, P. X., You, Y., Gong, J., & Liu, Z. (2018) · Cancer Medicine · doi:10.1002/cam4.1670 · Cited by 336
Lefebvre, E., Moyle, G., Reshef, R., Richman, L. P., Thompson, M., Hong, F., Chou, H.-L., Hashiguchi, T., Plato, C., Poulin, D., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158156 · Cited by 323
Germic, N., Frangez, Z., Yousefi, S., & Simon, H.-U. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-019-0297-6 · Cited by 315 · cited 1×
“Autophagy is essential for maintaining cellular homeostasis and signi fi cantly contributes to macrophage development, while also in fl uencing their apoptosis via modulation of colony-stimulating factors (55, 56).”
Lefere, S., Puengel, T., Hundertmark, J., Penners, C., Frank, A. K., Guillot, A., de Muynck, K., Heymann, F., Adarbes, V., Defrêne, E., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.025 · Cited by 310
Self-citationThe ascending pathophysiology of cholestatic liver disease
Jansen, P. L. M., Ghallab, A., Vartak, N., Reif, R., Schaap, F. G., Hampe, J., & Hengstler, J. G. (2017) · Hepatology · doi:10.1002/hep.28965 · Cited by 301 · cited 1×
“Cholestatic diseases such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are characterized by the retention of bilirubin and bile salts in the liver and elevations of these metabolites in systemic circulation with a signi fi cant impact on organ function (144).”
Ma, P.-F., Gao, C.-C., Yi, J., Zhao, J.-L., Liang, S.-Q., Zhao, Y., Ye, Y.-C., Bai, J., Zheng, Q.-J., Dou, K.-F., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.022 · Cited by 284
Contribution of metabolic reprogramming to macrophage plasticity and function
EL Kasmi, K. C., & Stenmark, K. R. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.09.001 · Cited by 277
Ni, Y., Nagashimada, M., Zhuge, F., Zhan, L., Nagata, N., Tsutsui, A., Nakanuma, Y., Kaneko, S., & Ota, T. (2015) · Scientific Reports · doi:10.1038/srep17192 · Cited by 261 · cited 1×
“Astaxanthin exhibits stronger antioxidant activity than b - carotene, and is particularly effective in reducing liver in fl ammation and inhibiting the activation of HSCs (174).”
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
Harrison, S. A., Goodman, Z., Jabbar, A., Vemulapalli, R., Younes, Z. H., Freilich, B., Sheikh, M. Y., Schattenberg, J. M., Kayali, Z., Zivony, A., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.024 · Cited by 260
Beattie, L., Sawtell, A., Mann, J., Frame, T. C. M., Teal, B., de Labastida Rivera, F., Brown, N., Walwyn-Brown, K., Moore, J. W. J., MacDonald, S., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.037 · Cited by 258 · cited 1×
“Furthermore, MoM f s can replace KCs when they are experimentally depleted due to liver injury, and these macrophages can subsequently acquire a phenotype that is almost identical to that of KCs (22, 23).”
NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation
Xu, J., Chi, F., Guo, T., Punj, V., Lee, W. N. P., French, S. W., & Tsukamoto, H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76468 · Cited by 241
Rao, J., Wang, H., Ni, M., Wang, Z., Wang, Z., Wei, S., Liu, M., Wang, P., Qiu, J., Zhang, L., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325150 · Cited by 241 · cited 1×
“Follistatin-like protein 1 (FSTL1) binds directly to PKM2 and promotes PKM2 phosphorylation and nuclear translocation (52).”
Verbeke, L., Mannaerts, I., Schierwagen, R., Govaere, O., Klein, S., Vander Elst, I., Windmolders, P., Farre, R., Wenes, M., Mazzone, M., et al. (2016) · Scientific Reports · doi:10.1038/srep33453 · Cited by 236
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
van der Heide, D., Weiskirchen, R., & Bansal, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02852 · Cited by 234 · cited 2×
“Although most macrophage-based therapies have been tested primarily in experimental animal models, some have been evaluated in clinical trials (155).”
Liu, T., Wang, L., Liang, P., Wang, X., Liu, Y., Cai, J., She, Y., Wang, D., Wang, Z., Guo, Z., et al. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00567-7 · Cited by 230
Self-citationMesenchymal stem cell therapy for liver fibrosis
Eom, Y. W., Shim, K. Y., & Baik, S. K. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.5.580 · Cited by 226
The Current State of Nanoparticle-Induced Macrophage Polarization and Reprogramming Research
Miao, X., Leng, X., & Zhang, Q. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020336 · Cited by 211 · cited 1×
“The polarization and reprogramming of macrophages can be differentially modulated by nanoparticles that vary in their physicochemical attributes, such as chemical makeup, size, and surface modi fi cation (195).”
David, B. A., Rezende, R. M., Antunes, M. M., Santos, M. M., Freitas Lopes, M. A., Diniz, A. B., Sousa Pereira, R. V., Marchesi, S. C., Alvarenga, D. M., Nakagaki, B. N., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.024 · Cited by 203
Regulatory Mechanism of M1/M2 Macrophage Polarization in the Development of Autoimmune Diseases
Peng, Y., Zhou, M., Yang, H., Qu, R., Qiu, Y., Hao, J., Bi, H., & Guo, D. (2023) · Mediators of Inflammation · doi:10.1155/2023/8821610 · Cited by 198
Xu, F., Guo, M., Huang, W., Feng, L., Zhu, J., Luo, K., Gao, J., Zheng, B., Kong, L.-D., Pang, T., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101634 · Cited by 196 · cited 1×
“Conversely, Annexin A5 targeting to PKM2 causes glycolysis inhibition and activation of mitochondrial oxidative metabolism, thereby triggering macrophages to switch to an anti-in fl ammatory phenotype (53).”
Kodama, Y., Kisseleva, T., Iwaisako, K., Miura, K., Taura, K., De Minicis, S., Österreicher, C. H., Schnabl, B., Seki, E., & Brenner, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.045 · Cited by 195
Kwon, H.-J., Won, Y.-S., Park, O., Chang, B., Duryee, M. J., Thiele, G. E., Matsumoto, A., Singh, S., Abdelmegeed, M. A., Song, B.-J., et al. (2014) · Hepatology · doi:10.1002/hep.27036 · Cited by 191
Anstee, Q. M., Neuschwander-Tetri, B. A., Wai-Sun Wong, V., Abdelmalek, M. F., Rodriguez-Araujo, G., Landgren, H., Park, G. S., Bedossa, P., Alkhouri, N., Tacke, F., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.04.003 · Cited by 179
Self-citationMacrophage Phenotype and Function in Liver Disorder
Dou, L., Shi, X., He, X., & Gao, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03112 · Cited by 178 · cited 1×
“A high HBV/HCV titer not only suppresses the polarization of pro-in fl ammatory macrophages, but also encourages their differentiation into a tolerogenic state (131).”
Metabolic influence on macrophage polarization and pathogenesis
Thapa, B., & Lee, K. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.6.140 · Cited by 172 · cited 2×
“Their TCA cycle remains intact, providing essential substrates for the electron transport chain (ETC).”
Inokuchi, S., Tsukamoto, H., Park, E., Liu, Z.-X., Brenner, D. A., & Seki, E. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01487.x · Cited by 171
Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis
Yang, Y. M., Noureddin, M., Liu, C., Ohashi, K., Kim, S. Y., Ramnath, D., Powell, E. E., Sweet, M. J., Roh, Y. S., Hsin, I.-F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat9284 · Cited by 166 · cited 1×
“The interaction between Jagged-1 on liver macrophages and Notch1 on HSCs drives Notch1-mediated HSCs activation and liver fi brosis (84).”
Self-citationAlcohol-associated liver disease—Global epidemiology
Åberg, F., Jiang, Z. G., Cortez-Pinto, H., & Männistö, V. (2024) · Hepatology · doi:10.1097/hep.0000000000000899 · Cited by 163
Slevin, E., Baiocchi, L., Wu, N., Ekser, B., Sato, K., Lin, E., Ceci, L., Chen, L., Lorenzo, S. R., Xu, W., et al. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.08.014 · Cited by 159 · cited 7×
“Intestinal barrier dysfunction is an important contributor to ALD.”
InfluentialSphingosine kinase 1 promotes liver fibrosis by preventing miR‐19b‐3p‐mediated inhibition of CCR2
Lan, T., Li, C., Yang, G., Sun, Y., Zhuang, L., Ou, Y., Li, H., Wang, G., Kisseleva, T., Brenner, D., et al. (2018) · Hepatology · doi:10.1002/hep.29885 · Cited by 153
Self-citationZhang, Q., Wang, C., Liu, Z., Liu, X., Han, C., Cao, X., & Li, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.310375 · Cited by 152
Wang, S., Chen, Z., Hu, C., Qian, F., Cheng, Y., Wu, M., Shi, B., Chen, J., Hu, Y., & Yuan, Z. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201625 · Cited by 152
Affò, S., Morales-Ibanez, O., Rodrigo-Torres, D., Altamirano, J., Blaya, D., Dapito, D. H., Millán, C., Coll, M., Caviglia, J. M., Arroyo, V., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306098 · Cited by 147
Wang, X., de Carvalho Ribeiro, M., Iracheta‐Vellve, A., Lowe, P., Ambade, A., Satishchandran, A., Bukong, T., Catalano, D., Kodys, K., & Szabo, G. (2019) · Hepatology · doi:10.1002/hep.30215 · Cited by 146
Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage
Perugorria, M. J., Esparza-Baquer, A., Oakley, F., Labiano, I., Korosec, A., Jais, A., Mann, J., Tiniakos, D., Santos-Laso, A., Arbelaiz, A., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-314107 · Cited by 144 · cited 1×
“Additionally, TREM2 ligation inhibits TLR4-driven in fl ammation in KCs (97).”
Gong, S., Zhai, M., Shi, J., Yu, G., Lei, Z., Shi, Y., Zeng, Y., Ju, P., Yang, N., Zhang, Z., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-023-01252-8 · Cited by 141 · cited 1×
“Notably, TREM2 also promotes lung fi brosis via protecting against macrophage apoptosis (107), while itaconate secreted by TREM2 + macrophages prevents apoptosis in cardiomyocytes and stimulates the growth of fi broblasts, which in turn enhances the process of cardiac tissue repair (108).”
Self-citationMacrophage Phenotype in Liver Injury and Repair
Sun, Y. ‐., Li, X. ‐., Meng, X. ‐., Huang, C., Zhang, L., & Li, J. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12468 · Cited by 137 · cited 1×
“Macrophages accelerate fi brosis by secreting various cytokines, including TGF-b 1, Vascular Endothelial Growth Factor (VEGF), and angiotensin II, which activate local tissue cells such as HSCs and myo fi broblasts (80).”
Targeting NFKB by autophagy to polarize hepatoma-associated macrophage differentiation
Chang, C.-P., Su, Y.-C., Lee, P.-H., & Lei, H.-Y. (2013) · Autophagy · doi:10.4161/auto.23546 · Cited by 133
Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease
Wu, X., Dong, L., Lin, X., & Li, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01728 · Cited by 132
CD5L Promotes M2 Macrophage Polarization through Autophagy-Mediated Upregulation of ID3
Sanjurjo, L., Aran, G., Téllez, É., Amézaga, N., Armengol, C., López, D., Prats, C., & Sarrias, M.-R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00480 · Cited by 132 · cited 1×
“Previous studies showed that cell division cycle 5-like (CD5L) regulates the up-regulation of inhibitor of DNA binding 3 (ID3) through the autophagy-related gene 7 (ATG7) and promotes an anti-in fl ammatory cytokine pro fi le in response to TLR activation (57).”
Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury
Hu, C., Zhao, L., Zhang, L., Bao, Q., & Li, L. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01895-1 · Cited by 130
Fan, G., Xie, T., Li, L., Tang, L., Han, X., & Shi, Y. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00564-3 · Cited by 130
Iron Reduces M1 Macrophage Polarization in RAW264.7 Macrophages Associated with Inhibition of STAT1
Gan, Z.-S., Wang, Q.-Q., Li, J.-H., Wang, X.-L., Wang, Y.-Z., & Du, H.-H. (2017) · Mediators of Inflammation · doi:10.1155/2017/8570818 · Cited by 126 · cited 1×
“For example, in pro-in fl ammatory macrophages, the expression of Hepcidin antimicrobial peptide (Hamp) and FtH/FtL is highly upregulated, while Ferroportin (FPN) and IRP1/2 are downregulated (63).”
Kim, B., Farruggia, C., Ku, C. S., Pham, T. X., Yang, Y. J., Bae, M., Wegner, C., Farrell, N., Harness, E., Park, Y., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.01.006 · Cited by 122
Self-citationLi, X., Liu, R., Wang, Y., Zhu, W., Zhao, D., Wang, X., Yang, H., Gurley, E. C., Chen, W., Hylemon, P. B., et al. (2020) · Cells · doi:10.3390/cells9010190 · Cited by 119
Zhou, S., Gu, J., Liu, R., Wei, S., Wang, Q., Shen, H., Dai, Y., Zhou, H., Zhang, F., & Lu, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00948 · Cited by 116
Liver Fibrosis in Alcoholic Liver Disease
Gao, B., & Bataller, R. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1550054 · Cited by 114
Yu, Y., & Richardson, D. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225946 · Cited by 107
MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization
Zhang, J., Liu, Y., Chen, H., Yuan, Q., Wang, J., Niu, M., Hou, L., Gu, J., & Zhang, J. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04802-z · Cited by 107
Self-citationMcGettigan, B., McMahan, R., Orlicky, D., Burchill, M., Danhorn, T., Francis, P., Cheng, L. L., Golden‐Mason, L., Jakubzick, C. V., & Rosen, H. R. (2019) · Hepatology · doi:10.1002/hep.30401 · Cited by 106
Ni, Y., Nagashimada, M., Zhan, L., Nagata, N., Kobori, M., Sugiura, M., Ogawa, K., Kaneko, S., & Ota, T. (2015) · Endocrinology · doi:10.1210/en.2014-1776 · Cited by 104
Qing, J., Ren, Y., Zhang, Y., Yan, M., Zhang, H., Wu, D., Ma, Y., Chen, Y., Huang, X., Wu, Q., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.032 · Cited by 103
Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection
Faure-Dupuy, S., Delphin, M., Aillot, L., Dimier, L., Lebossé, F., Fresquet, J., Parent, R., Matter, M. S., Rivoire, M., Bendriss-Vermare, N., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.032 · Cited by 102
Heterogeneity and Function of Kupffer Cells in Liver Injury
Li, W., Chang, N., & Li, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940867 · Cited by 102 · cited 1×
“KCs help maintain liver homeostasis and play important modulatory roles in bacterial clearance, antigen presentation, and modulation of iron/lipid metabolism (14).”
Histidine‐rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease
Bartneck, M., Fech, V., Ehling, J., Govaere, O., Warzecha, K. T., Hittatiya, K., Vucur, M., Gautheron, J., Luedde, T., Trautwein, C., et al. (2016) · Hepatology · doi:10.1002/hep.28418 · Cited by 101
Self-citationMacrophage HIF-2α Ameliorates Adipose Tissue Inflammation and Insulin Resistance in Obesity
Choe, S. S., Shin, K. C., Ka, S., Lee, Y. K., Chun, J.-S., & Kim, J. B. (2014) · Diabetes · doi:10.2337/db13-1965 · Cited by 100
Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
Lin, L., Gong, H., Li, R., Huang, J., Cai, M., Lan, T., Huang, W., Guo, Y., Zhou, Z., An, Y., et al. (2020) · Advanced Science · doi:10.1002/advs.201903138 · Cited by 100 · cited 1×
“A polydatin-loaded micelle demonstrates highly ef fi cient liver-targeted drug release in response to the fi brotic microenvironment (197).”
Self-citationAdvances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
Yin, X., Guo, X., Liu, Z., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032844 · Cited by 100 · cited 1×
“The spectrum of MASLD extends from hepatic steatosis to metabolic dysfunction-associated steatohepatitis (MASH), which may progress to advanced liver fi brosis, cirrhosis, or even hepatocellular carcinoma (HCC) (89).”
Keewan, E., & Naser, S. A. (2020) · Cells · doi:10.3390/cells9010111 · Cited by 98
Chu, P.-S., Nakamoto, N., Ebinuma, H., Usui, S., Saeki, K., Matsumoto, A., Mikami, Y., Sugiyama, K., Tomita, K., Kanai, T., et al. (2013) · Hepatology · doi:10.1002/hep.26351 · Cited by 97 · cited 1×
“Moreover, CCR9-de fi cient HSCs exhibit reduced fi brotic potential in vitro ( 170).”
Eslam, M., McLeod, D. J., Kelaeng, K. S., Mangia, A., Berg, T., Thabet, K., Irving, W. L., Dore, G. J., Sheridan, D. A., Grønbæk, H., et al. (2017) · Nature Genetics · doi:10.1038/ng.3836 · Cited by 97
Short-term memory of danger signals and environmental stimuli in immune cells
Monticelli, S., & Natoli, G. (2013) · Nature Immunology · doi:10.1038/ni.2636 · Cited by 95 · cited 1×
“This adaptive “ short-term memory ” mechanism induces transient yet sustained modi fi cations in macrophage phenotypes, thereby dynamically in fl uencing their pathogenic contributions during disease progression (41).”
Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair
De Ponti, F. F., Bujko, A., Liu, Z., Collins, P. J., Schuermans, S., Maueroder, C., Amstelveen, S., Thoné, T., Martens, L., McKendrick, J. G., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.01.002 · Cited by 94 · cited 1×
“Genetic deletion of TREM2 in LAMs signi fi cantly impairs their tissue repair capacity, leading to exacerbated macrophage-mediated hepatic in fl ammation and accelerated fi brogenesis (100, 101).”
Jeftic, I., Jovicic, N., Pantic, J., Arsenijevic, N., Lukic, M. L., & Pejnovic, N. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00178 · Cited by 89
Bae, S., Park, P. S. U., Lee, Y., Mun, S. H., Γιαννοπούλου, Ε., Fujii, T., Lee, K. P., Violante, S. N., Cross, J. R., & Park‐Min, K. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109264 · Cited by 89
Wilkinson, H. N., Roberts, E. R., Stafford, A. R., Banyard, K. L., Matteucci, P. L., Mace, K. A., & Hardman, M. J. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.07.015 · Cited by 86
Puengel, T., De Vos, S., Hundertmark, J., Kohlhepp, M., Guldiken, N., Pujuguet, P., Auberval, M., Marsais, F., Shoji, K. F., Saniere, L., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041140 · Cited by 85
Self-citationLi, Y., He, M., Wang, Z., Duan, Z., Guo, Z., Wang, Z., Gong, R., Chu, T., Cai, J., & Gao, B. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00801-w · Cited by 85
Shi, H., Wang, X., Li, F., Gerlach, B. D., Yurdagul, A., Moore, M. P., Zeldin, S., Zhang, H., Cai, B., Zheng, Z., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abp8309 · Cited by 85
Navarro, L. A., Wree, A., Povero, D., Berk, M. P., Eguchi, A., Ghosh, S., Papouchado, B. G., Erzurum, S. C., & Feldstein, A. E. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.09.015 · Cited by 84 · cited 1×
“For instance, arginase-2 knockout mice develop spontaneous steatohepatitis, which can be mitigated by KCs depletion (93).”
Alternative splicing of hepatitis B virus: A novel virus/host interaction altering liver immunity
Duriez, M., Mandouri, Y., Lekbaby, B., Wang, H., Schnuriger, A., Redelsperger, F., Guerrera, I. C., Lefèvre, M., Fauveau, V., Ahodantin, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.025 · Cited by 84 · cited 1×
“Similarly, HBV splicing-generated protein (HBSP) impacts liver monocyte/macrophage recruitment through a down-regulation of hepatocyte CCL2 expression upon acute liver injury (134).”
The Landscape of SPP1 + Macrophages Across Tissues and Diseases: A Comprehensive Review
Palma, A. (2025) · Immunology · doi:10.1111/imm.13952 · Cited by 81 · cited 1×
“SPP1 has been reported to be upregulated in liver fi brosis and is tightly linked to dismal prognosis in end-stage hepatocellular carcinoma (103, 104).”
Li, H., Zheng, H., Chen, H., Xing, Z., You, H., Cong, M., & Jia, J. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.11.005 · Cited by 79
Li, X., Huai, Q., Zhu, C., Zhang, X., Xu, W., Dai, H., & Wang, H. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.07.009 · Cited by 77
Macrophage Coordination of the Interferon Lambda Immune Response
Read, S. A., Wijaya, R. S., Ramezani–Moghadam, M., Tay, E. S. E., Schibeci, S., Liddle, C., Lam, V. W. T., Yuen, L., Douglas, M. W., Booth, D. R., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02674 · Cited by 75
CD11b+CD43hiLy6Clo splenocyte‐derived macrophages exacerbate liver fibrosis via spleen–liver axis
Zhang, S., Wan, D., Zhu, M., Wang, G., Zhang, X., Huang, N., Zhang, J., Zhang, C., Shang, Q., Zhang, C., et al. (2023) · Hepatology · doi:10.1002/hep.32782 · Cited by 75 · cited 1×
“In another study, a subtype of spleen ‐ derived monocytes identi fi ed as CD11b + CD43 hi Ly6C lo cells has been demonstrated to preferentially in fi ltrate fi brotic liver tissue and adopt macrophage characteristics, thereby exacerbating fi brogenesis (30).”
TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity
Cui, H., Banerjee, S., Xie, N., Hussain, M., Jaiswal, A., Liu, H., Kulkarni, T., Antony, V. B., Liu, R.-M., Colonna, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57024-0 · Cited by 74 · cited 1×
“Notably, TREM2 also promotes lung fi brosis via protecting against macrophage apoptosis (107), while itaconate secreted by TREM2 + macrophages prevents apoptosis in cardiomyocytes and stimulates the growth of fi broblasts, which in turn enhances the process of cardiac tissue repair (108).”
Understanding the complex macrophage landscape in MASLD
Ponti, F. F. D., Liu, Z., & Scott, C. L. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101196 · Cited by 72
HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis
Xie, X., Lv, H., Liu, C., Su, X., Yu, Z., Song, S., Bian, H., Tian, M., Qin, C., Qi, J., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02085-3 · Cited by 67
Macrophage Phenotypes and Hepatitis B Virus Infection
Li, Y., Li, S., Duan, X., Yang, C., Xu, M., & Chen, L. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00046 · Cited by 66 · cited 1×
“Both adaptive and innate immunity are involved in the immune response to viral hepatitis, and the essential role of non-speci fi c defense — especially the function of hepatic macrophages — has received wide attention (130).”
Self-citationLi, Z., Feng, P.-P., Zhao, Z.-B., Zhu, W., Gong, J.-P., & Du, H.-M. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.149 · Cited by 65
De Muynck, K., Heyerick, L., De Ponti, F. F., Vanderborght, B., Meese, T., Van Campenhout, S., Baudonck, L., Gijbels, E., Rodrigues, P. M., Banales, J. M., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000557 · Cited by 64
Li, L., Wei, W., Li, Z., Chen, H., Li, Y., Jiang, W., Chen, W., Kong, G., Yang, J., & Li, Z. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495276 · Cited by 62 · cited 1×
“SMs enhance the secretion of CCL2 by hepatic macrophages, which in turn facilitates monocyte recruitment and the augmentation of liver fi brosis (29).”
Macrophage-specific FGF12 promotes liver fibrosis progression in mice
Li, S., Zhou, B., Xue, M., Zhu, J., Tong, G., Fan, J., Zhu, K., Hu, Z., Chen, R., Dong, Y., et al. (2023) · Hepatology · doi:10.1002/hep.32640 · Cited by 62
Self-citationMacrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications
Chi, Y., Jiang, H., Yin, Y., Zhou, X., Shao, Y., Li, Y., & Rao, J. (2025) · MedComm · doi:10.1002/mco2.70256 · Cited by 62 · cited 2×
“In macrophage polarization, this pathway modulates the transition between pro-in fl ammatory and anti-in fl ammatory phenotypes through selective activation of distinct STAT isoforms (68).”
SPP1 macrophages across diseases: A call for reclassification?
Reggio, A., Fuoco, C., Deodati, R., & Palma, A. (2025) · The FASEB Journal · doi:10.1096/fj.202403227r · Cited by 57 · cited 1×
“Among these cells, the existence of specialized subpopulations with distinct functional roles in health and disease has been documented (76).”
Ravichandran, G., Neumann, K., Berkhout, L. K., Weidemann, S., Langeneckert, A. E., Schwinge, D., Poch, T., Huber, S., Schiller, B., Hess, L. U., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.023 · Cited by 56
Barnes, M. A., McMullen, M. R., Roychowdhury, S., Madhun, N. Z., Niese, K., Olman, M. A., Stavitsky, A. B., Bucala, R., & Nagy, L. E. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0614-280r · Cited by 53
Macrophage Polarization, Metabolic Reprogramming, and Inflammatory Effects in Ischemic Heart Disease
Sun, X., Li, Y., Deng, Q., Hu, Y., Dong, J., Wang, W., Wang, Y., & Li, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.934040 · Cited by 51 · cited 1×
“In quiescent conditions, macrophages predominantly utilize tricarboxylic acid (TCA) cycle coupled with oxidative phosphorylation (OXPHOS) to generate Adenosine triphosphate (ATP), establishing energy equilibrium through mitochondrial respiration (43).”
Self-citationJin, H., Liu, K., Tang, J., Huang, X., Wang, H., Zhang, Q., Zhu, H., Li, Y., Pu, W., Zhao, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23197-7 · Cited by 50
Macrophage Motility in Wound Healing Is Regulated by HIF-1α via S1P Signaling
Hutami, I. R., Izawa, T., Khurel‐Ochir, T., Sakamaki, T., Iwasa, A., & Tanaka, E. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168992 · Cited by 50 · cited 1×
“Moreover, HIF-1 a exerts a regulatory in fl uence on sphingosine 1-phosphate (S1P) metabolism, thereby modulating the migration, activation, differentiation, and polarization of macrophages (45).”
MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis
Yu, W., Wang, S., Wang, Y., Chen, H., Nie, H., Liu, L., Zou, X., Gong, Q., & Zheng, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147710 · Cited by 50
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
Greenman, R., Segal-Salto, M., Barashi, N., Hay, O., Katav, A., Levi, O., Vaknin, I., Aricha, R., Aharoni, S., Snir, T., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.162270 · Cited by 48
Liang, S., Zhong, Z., Kim, S. Y., Uchiyama, R., Roh, Y. S., Matsushita, H., Gottlieb, R. A., & Seki, E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007409 · Cited by 47
Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview
Pinheiro, D., Dias, I., Ribeiro Silva, K., Stumbo, A. C., Thole, A., Cortez, E., de Carvalho, L., Weiskirchen, R., & Carvalho, S. (2019) · Cells · doi:10.3390/cells8111339 · Cited by 46 · cited 1×
“In addition, mesenchymal stem cells can inhibit the in fl ammatory response, reduce hepatocyte apoptosis, promote hepatocyte regeneration, attenuate liver fi brosis, and enhance liver function (191).”
Wu, T., Zhang, C., Shao, T., Chen, J., & Chen, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.905423 · Cited by 46
Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis
Xiong, S., She, H., Zhang, A.-S., Wang, J., Mkrtchyan, H., Dynnyk, A., Gordeuk, V. R., French, S. W., Enns, C. A., & Tsukamoto, H. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90327.2008 · Cited by 45
Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis
Peng, W., Cheng, S., Bao, Z., Wang, Y., Zhou, W., Wang, J., Yang, Q., Chen, C., & Wang, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111342 · Cited by 45 · cited 2×
“This approach holds signi fi cant promise for the treatment of liver fi brosis (196).”
Self-citationZhu, J., Jin, Z., Wang, J., Wu, Z., Xu, T., Tong, G., Shen, E., Fan, J., Jiang, C., Wang, J., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.004 · Cited by 43
Hepatic Macrophage Responses in Inflammation, a Function of Plasticity, Heterogeneity or Both?
Zwicker, C., Bujko, A., & Scott, C. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690813 · Cited by 41 · cited 1×
“This classi fi cation was based on the differential responses of macrophages in vitro to stimuli (32).”
Huang, H.-Y., Chen, Y.-Z., Zhao, C., Zheng, X.-N., Yu, K., Yue, J., Ju, H., Shi, Y., & Tian, L. H. (2024) · Nature Communications · doi:10.1038/s41467-024-53659-7 · Cited by 41 · cited 1×
“Multiple lineage-tracing models have shown that MoM f s are also the major population of immunosuppressive and liver metastasis-associated macrophages (LMAM) (21).”
Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis
Morikawa, R., Nakamoto, N., Amiya, T., Chu, P.-S., Koda, Y., Teratani, T., Suzuki, T., Kurebayashi, Y., Ueno, A., Taniki, N., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.033 · Cited by 40 · cited 1×
“Blocking the CCR9/CCL25 axis with a CCR9 antagonist represents an effective approach to mitigate the progression of hepatic fi brosis (171).”
Wang, Y., Huang, S., Kong, W., Wu, C., Zeng, T., Xie, S., Chen, Q., Kuang, S., Zheng, R., Wang, F., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155016 · Cited by 40
Azad, A. I., Krishnan, A., Troop, L., Li, Y., Katsumi, T., Pavelko, K., Kostallari, E., Guicciardi, M. E., & Gores, G. J. (2020) · Hepatology · doi:10.1002/hep.31211 · Cited by 39
Galectin-3: therapeutic targeting in liver disease
Mackinnon, A. C., Tonev, D., Jacoby, B., Pinzani, M., & Slack, R. J. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2258280 · Cited by 38
Duan, B., Liu, Y., Li, X., Han, M., Yu, H., Hong, H., Zhang, L., Xing, L., & Jiang, H. (2024) · Advanced Science · doi:10.1002/advs.202306899 · Cited by 38
Self-citationAdvances in multi-omics research on viral hepatitis
Xiang, Z., Li, J., Lu, D., Wei, X., & Xu, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.987324 · Cited by 37 · cited 1×
“The global prevalence of viral hepatitis is predominantly attributed to fi ve distinct hepatotropic viruses that are biologically unrelated, including hepatitis B virus (HBV), hepatitis C virus (HCV) among others (128).”
García‐Ruíz, I., Ruiz, N. B., Rada, P., Pardo, V., Ruíz-Cañas, L., Blas‐García, A., Valdecantos, M. P., Sanz, M., Herruzo, J. A. S., & Valverde, Á. M. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101263 · Cited by 36
Kumar, V., Mansfield, J. A., Fan, R., MacLean, A. G., Li, J., & Mohan, M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701148 · Cited by 35
Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis
Allina, J., Stanca, C. M., Garber, J. J., Hu, B., Sautès‐Fridman, C., Bach, N., & Odin, J. A. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.10.003 · Cited by 34
The diverse roles of macrophages in metabolic inflammation and its resolution
Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 34
Song, X., Gao, X. M., Wang, Y., Raja, R., Zhang, Y., Yang, S., Li, M., Yao, Z., & Wei, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654998 · Cited by 31 · cited 1×
“In agreement with the fi nding, HCV core protein can inhibit the NF-k B pathway to greatly reduce the expression of CCL2 and CXCL10 in macrophages (133).”
Biagioli, M., Marchianò, S., Giorgio, C. D., Bordoni, M., Urbani, G., Bellini, R., Massa, C., Khan, R. S. U., Roselli, R., Monti, M. C., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115900 · Cited by 30
Saldarriaga, Ó. A., Wanninger, T. G., Arroyave, E., Gosnell, J., Krishnan, S., Oneka, M. D., Bao, D., Millian, D. E., Kueht, M., Moghe, A., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100958 · Cited by 28
TREM2 in MASH: integrating lipid metabolism and immune response
Shi, S., Zhou, Y. Y., Zhang, H., & Zhang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1604837 · Cited by 28 · cited 12×
“However, CVC maintained a favorable safety pro fi le and was well tolerated in this cohort with MASH and liver fi brosis (168).”
InfluentialMacrophages and autophagy: partners in crime
Vitaliti, A., Reggio, A., & Palma, A. (2024) · FEBS Journal · doi:10.1111/febs.17305 · Cited by 27 · cited 1×
“Autophagy is essential for maintaining cellular homeostasis and signi fi cantly contributes to macrophage development, while also in fl uencing their apoptosis via modulation of colony-stimulating factors (55, 56).”
TREM2-expressing macrophages in liver diseases
Wang, X., Qiu, Z., Zhong, Z., & Liang, S. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.04.009 · Cited by 27 · cited 1×
“Genetic deletion of TREM2 in LAMs signi fi cantly impairs their tissue repair capacity, leading to exacerbated macrophage-mediated hepatic in fl ammation and accelerated fi brogenesis (100, 101).”
Notch signaling and M1 macrophage activation in obesity-alcohol synergism
Xu, J., Chi, F., & Tsukamoto, H. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.016 · Cited by 26
Wang, H., Li, L., Li, Y., Li, Y., Sha, Y., Wen, S., You, Q., Liu, L., Shi, M., & Zhou, H. (2020) · Theranostics · doi:10.7150/thno.51369 · Cited by 26 · cited 1×
“In contrast, during the course of steatohepatitis, KCs tend to form clusters and lose their typical villus-like or digit-like extensions (90).”
BRP39 Regulates Neutrophil Recruitment in NLRP3 Inflammasome-Induced Liver Inflammation
Kui, L., Kim, A. D., Onyuru, J., Hoffman, H. M., & Feldstein, A. E. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.12.002 · Cited by 24
Guan, D., Huang, P., Liu, X., Li, Q., Zhang, X., Liu, N., Wang, Y., Wan, Y., Chai, J., Cai, S., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.11.020 · Cited by 24 · cited 7×
“The genes elevated in MASLD have also been found to regulate macrophage polarization.”
InfluentialSphingosine Kinase 1 Aggravates Liver Fibrosis by Mediating Macrophage Recruitment and Polarization
Ding, X., Zhang, X., Cao, J., Chen, S., Chen, Y., Yuan, K., Chen, B., Yang, G., Li, S., Yang, J., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101406 · Cited by 23
Self-citationAhamed, F., Eppler, N., Jones, E., & Zhang, Y. (2024) · Livers · doi:10.3390/livers4030033 · Cited by 22
Reuveni, D., Brezis, M. R., Brazowski, E., Vinestock, P., Leung, P. S. C., Thakker, P., Gershwin, M. E., & Zigmond, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718841 · Cited by 21
Song, G., Shi, Y., Meng, L. M., Ma, J., Huang, S., Zhang, J., Wu, Y. C., Li, J., Lin, Y., Yang, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30599-8 · Cited by 21
Self-citationGiorgio, C. D., Urbani, G., Marchianò, S., Biagioli, M., Bordoni, M., Bellini, R., Massa, C., Lachi, G., Cari, L., Morretta, E., et al. (2025) · Liver International · doi:10.1111/liv.16235 · Cited by 20
Gao, Z., Li, X., Feng, S.-R., Chen, J., Song, K., Shi, Y., Tang, Z., Liu, W., Zhang, X., Huang, A., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110685 · Cited by 18
Liver Macrophage Diversity in Health and Disease
Horn, P., & Tacke, F. (2024) · Results and problems in cell differentiation · doi:10.1007/978-3-031-65944-7_7 · Cited by 17 · cited 1×
“These include immune responses, protection against infections, and the modulation of metabolic processes (4).”
Self-citationPang, Q., Zhou, S., Wang, Y., Pan, H., Wang, Z., Qin, X., Zhu, C., Chen, S., Liu, H., Hu, X., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103509 · Cited by 17
Self-citationHepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
Kholodenko, I. V., & Yarygin, K. N. (2023) · Biomedicines · doi:10.3390/biomedicines11113056 · Cited by 16 · cited 1×
“Among these in fl ammatory cells, Ly-6C hi MoM f s are particularly reliant on the signaling pathways involving CCL2/ CCR2, CCL1/CCR8, and CCL25/CCR9 (165).”
Fu, H., Bao, W.-M., Yang, C., Lai, W.-J., Xu, J., Yu, H., Yang, Y., Tan, X., Gupta, A. K., & Tang, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.923726 · Cited by 15
Self-citationZhuang, L., Jia, N., Zhang, L., Zhang, Q., Antwi, S. O., Sartorius, K., Wu, K., Sun, D., Xi, D., & Lu, Y. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167266 · Cited by 13
Yang, Y., Li, W., Liu, C., Liu, J., Yang, L., Yue, W., Yang, L., Xue, R., Zhang, K., Zhang, H., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166754 · Cited by 12
Self-citationGPNMB regulates the differentiation and transformation of monocyte-derived macrophages during MASLD
Wang, J., Wang, H., Yang, W., Zhao, D., Liu, D., Tang, L., & Chen, X. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114554 · Cited by 12
Li, C., Fang, L., Su, X., Zhang, J., Xiong, H., Yu, H., Zhu, Z., Lin, X., Min, K., Wu, D., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07574-4 · Cited by 11
Role of Macrophages in Liver Fibrosis.
Sun, C., & Matsukawa, A. (2024) · Institutional Repositories DataBase (IRDB) · doi:10.18926/amo/66664 · Cited by 10
Viral hepatitis elimination — time to act
(2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00963-8 · Cited by 9
Oza, D., Ivich, F., Deprey, K., Bittner, K., Bailey, K., Goldman, S., Yu, M., Niedre, M., Tu, H.-C., & Amiji, M. M. (2025) · ACS Nano · doi:10.1021/acsnano.4c18345 · Cited by 9
Liu, X., Rong-Rong, W. E. I., Wang, C.-C., Chen, L.-Y., Liu, C., & Liu, K. (2018) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1705-32 · Cited by 6
β-cryptoxanthin and fatty liver disease: new insights
Clugston, R. D. (2023) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-23-201 · Cited by 4 · cited 1×
“…(155). b -cryptoxanthin, a lutein carotenoid, has been shown to exert protective effects on markers of hepatic fat accumulation and in fl ammation (172). b -cryptoxanthin can directly attenuate LPS-induced pro-in fl ammatory macrophage activation while enhancing IL-4-induced alternatively…”
Farnesoid X Receptor-Mediated Changes to Macrophage Cytokine Expression
Anderson, K. M., Handler, D. A., & Gayer, C. P. (2021) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2021.07.375 · Cited by 1
Cited by
Li, Y. C., Hu, Y., He, Y. M., Yang, Y., Xue, D., Xue, E., Jia, J., Zhang, W., & Wang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1793092 · Cited by 6
“This integrative perspective helps explain why interventions solely targeting in fl ammatory pathways often fail to reverse established fi brosis (133), and further suggests that strategies aimed at improving intestinal barrier integrity and restoring metabolic homeostasis may serve as complementary…”
Self-citationWan, Q., Fang, Z., Shi, J., Jiang, Y., Jin, H., Sui, C., Liu, X., An, F., Zhang, Y., Chen, Z., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093731 · Cited by 4
“However, with the development of high-throughput technologies, such as single-cell RNA sequencing (scRNA-seq), researchers have found that macrophage heterogeneity goes far beyond this binary M1/M2 classification [18–20].”
Yao, Q., Peng, W., Lu, H., Yang, Y., Rao, Z., Xie, X., Huang, D. A., Wang, W., Yan, J., & Liu, J. (2025) · Molecules · doi:10.3390/molecules30234571 · Cited by 2
“…hepatic macrophages are of significant therapeutic interest due to their central role in normal tissue homeostasis and their dual functions in promoting and inhibiting fibrosis, making them attractive targets for therapeutic intervention in experimental animal models and clinical trials [7,8].”
Self-citationLiver Macrophages in the Pathogenesis of Viral Hepatitis
Tsomidis, I., Tsakou, A., Voumvouraki, A., & Kouroumalis, E. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070687 · Cited by 2
“BMDM recruitment initiation is mediated through activated TLR signaling in KCs or HSCs resulting in increased production of CCL2 [31,32].”
Zhu, L., & Wu, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1899587 · Cited by 1
Metadata
- Authors
- Wang, W., Li, S., Liu, Y., Ding, X., Yang, Y., Chen, S., Cao, J., Tacke, F., Dong, W., & Lan, T.
- Affiliations
- Harbin Medical University (CN)
- Guangdong Pharmaceutical University (CN)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Lan, Tian
- ORCID
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2025-09-04
- Volume
- 16
- Pages
- 1639455-1639455
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC12443557
- OpenAlex
- W4414000305
- Cited by
- 8
- References
- 198
- Citations by year
- 2026: 6 · 2025: 2
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China
- Science and Technology Planning Project of Guangdong Province
- Natural Science Foundation of Heilongjiang Province
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- liver fibrosis, hepatic macrophages, macrophage heterogeneity, macrophage plasticity, macrophage polarization, chronic liver injury, fibrogenesis, fibrosis regression, macrophage-targeted therapy, single-cell omics, spatial omics
- MeSH terms
- Animals, Humans, Liver, Liver Cirrhosis, Macrophages
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.